Product Information
Name:TAK-828F
Brand:Biosynth
Description:TAK-828F is a monoclonal antibody that targets IL-17A. IL-17A is an inflammatory cytokine that has been shown to play a role in the development of autoimmune diseases and bowel disease. TAK-828F binds to IL-17A with high affinity and specificity, inhibiting its inflammatory effects on the immune system. TAK-828F was studied in clinical trials for use in the treatment of Crohn's disease, ulcerative colitis, and psoriasis. The drug was successful in treating Crohn's disease and psoriasis but not ulcerative colitis. TAK-828F is currently being developed for use as a treatment for inflammatory bowel disease and other autoimmune diseases.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:509.6 g/mol
Formula:C28H32FN3O5
Purity:Min. 95%
Technical inquiry about: TAK-828F
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.